Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001415889-24-027107

CHIEF FINANCIAL OFFICER acquired 15,816 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Andrade Robert CHIEF FINANCIAL OFFICER 2024-11-18 Option exercise +15,816 $2.45 $38,749 127,381 D
Derivatives
Andrade Robert CHIEF FINANCIAL OFFICER 2024-11-18 Option exercise · Stock Options −15,816 $2.45 $38,749 689,184 D
Loading xslF345X05/form4-11182024_101148.xml…